Importance of B cell co-stimulation in CD4+ T cell differentiation: X-linked agammaglobulinaemia, a human model

Clinical and Experimental Immunology

Volumn 164, Issue 3, 2011, Pages 381-387

  Martini, H ^a,b   Enright, V ^a   Perro, M ^a   Workman, S ^a   Birmelin, J ^a   Giorda, E ^c   Quinti, I ^b   Lougaris, V ^d   Baronio, M ^d   Warnatz, K ^e   Grimbacher, B ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

CD4+ T memory cells; CD4+CD45RO+CXCR5+ cells; TFH cells; XLA

Indexed keywords

PROTEIN TYROSINE KINASE;

ADULT; ARTICLE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; GENE MUTATION; GERMINAL CENTER; HUMAN; LYMPHOCYTE DIFFERENTIATION; MALE; PRIORITY JOURNAL; X LINKED AGAMMAGLOBULINEMIA;

ADOLESCENT; ADULT; AGAMMAGLOBULINEMIA; ANTIGENS, CD45; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL SEPARATION; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; FLOW CYTOMETRY; GENETIC DISEASES, X-LINKED; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; MUTATION; PROTEIN-TYROSINE KINASES; RECEPTORS, CXCR5;

EID: 79955481864     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04377.x     Document Type: Article

References (50)

1. Lanzavecchia A. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu Rev Immunol 1990; 8:773-93.
2. Parker DC. T cell-dependent B cell activation. Annu Rev Immunol 1993; 11:331-60.
3. Janeway CA Jr, Ron J, Katz ME. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J Immunol 1987; 138:1051-5.
4. Ron Y, Sprent J. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J Immunol 1987; 138:2848-56.
5. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature 1985; 314:537-9.
6. Garside P, Ingulli E, Merica RR, Johnson JG, Noelle RJ, Jenkins MK. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 1998; 281:96-9.
7. Rodriguez-Pinto D, Moreno J. B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner. Eur J Immunol 2005; 35:1097-105.
8. Linton PJ, Bautista B, Biederman E etal. Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J Exp Med 2003; 197:875-83.
9. Sfikakis PP, Boletis JN, Lionaki S etal. Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial. Arthritis Rheum 2005; 52:501-13.
10. Tafuri A, Shahinian A, Bladt F etal. ICOS is essential for effective T-helper-cell responses. Nature 2001; 409:105-9.
11. McAdam AJ, Greenwald RJ, Levin MA etal. ICOS is critical for CD40-mediated antibody class switching. Nature 2001; 409:102-5.
12. Dong C, Juedes AE, Temann UA etal. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 2001; 409:97-101.
13. Liu Y, Wu Y, Ramarathinam L etal. Gene-targeted B-deficient mice reveal a critical role for B cells in the CD4 T cell response. Int Immunol 1995; 7:1353-62.
14. Linton PJ, Harbertson J, Bradley LM. A critical role for B cells in the development of memory CD4 cells. J Immunol 2000; 165:5558-65.
15. Crawford A, Macleod M, Schumacher T, Corlett L, Gray D. Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J Immunol 2006; 176:3498-506.
16. Joao C, Ogle BM, Gay-Rabinstein C, Platt JL, Cascalho M. B cell-dependent TCR diversification. J Immunol 2004; 172:4709-16.
17. AbuAttieh M, Rebrovich M, Wettstein PJ etal. Fitness of cell-mediated immunity independent of repertoire diversity. J Immunol 2007; 178:2950-60.
18. Moulin V, Andris F, Thielemans K, Maliszewski C, Urbain J, Moser M. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med 2000; 192:475-82.
19. Ngo VN, Cornall RJ, Cyster JG. Splenic T zone development is B cell dependent. J Exp Med 2001; 194:1649-60.
20. Golovkina TV, Shlomchik M, Hannum L, Chervonsky A. Organogenic role of B lymphocytes in mucosal immunity. Science 1999; 286:1965-8.
21. Bouaziz JD, Yanaba K, Venturi GM etal. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc Natl Acad Sci USA 2007; 104:20882-7.
22. Xiu Y, Wong CP, Bouaziz JD etal. B lymphocytes depletion by CD20 monoclonal antibody prevents diabetes in NOD mice despite isotype-specific differences in FcγR effector functions. J Immunol 2008; 180:2863-75.
23. Conley ME. B cells in patients with X-linked agammaglobulinemia. J Immunol 1985; 134:3070-4.
24. Campana D, Farrant J, Inamdar N, Webster AD, Janossy G. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J Immunol 1990; 145:1675-80.
25. Crockard AD, Boyd NA, McNeill TA, McCluskey DR. CD4 lymphocyte subset abnormalities associated with impaired delayed cutaneous hypersensitivity reactions in patients with X-linked agammaglobulinaemia. Clin Exp Immunol 1992; 88:29-34.
26. Plebani A, Fischer MB, Meini A, Duse M, Thon V, Eibl MM. T cell activity and cytokine production in X-linked agammaglobulinemia: implications for vaccination strategies. Int Arch Allergy Immunol 1997; 114:90-3.
27. Paroli M, Accapezzato D, Francavilla V etal. Long-lasting memory-resting and memory-effector CD4+ T cells in human X-linked agammaglobulinemia. Blood 2002; 99:2131-7.
28. Morales-Aza B, Glennie SJ, Garcez TP etal. Impaired maintenance of naturally acquired T-cell memory to the meningococcus in patients with B-cell immunodeficiency. Blood 2009; 113:4206-12.
29. Ronchese F, Hausmann B. B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes. J Exp Med 1993; 177:679-90.
30. Tamimoto Y, Horiuchi T, Tsukamoto H etal. A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans' syndrome: immunological analysis of B cells, T cells and cytokines. Rheumatology 2008; 47:821-7.
31. Stasi R, Del Poeta G, Stipa E etal. Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura. Blood 2007; 110:2924-30.
32. Vallerskog T, Gunnarsson I, Widhe M etal. Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin Immunol 2007; 122:62-74.
33. de Weers M, Verschuren MC, Kraakman ME etal. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. Eur J Immunol 1993; 23:3109-14.
34. Muller S, Sideras P, Smith CI, Xanthopoulos KG. Cell specific expression of human Bruton's agammaglobulinemia tyrosine kinase gene (Btk) is regulated by Sp1- and Spi-1/PU.1-family members. Oncogene 1996; 13:1955-64.
35. Lachance G, Levasseur S, Naccache PH. Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils: implication of phosphatidynositol 3-kinases. J Biol Chem 2002; 277:21537-41.
36. Gilbert C, Levasseur S, Desaulniers P etal. Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils, II: effects of LFM-A13, a specific Btk inhibitor. J Immunol 2003; 170:5235-43.
37. Mangla A, Khare A, Vineeth V etal. Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses. Blood 2004; 104:1191-7.
38. Hata D, Kawakami Y, Inagaki N etal. Involvement of Bruton's tyrosine kinase in FcepsilonRI dependent mast cell degranulation and cytokine production. J Exp Med 1998; 187:1235-47.
39. Kawakami Y, Kitaura J, Satterthwaite AB etal. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation. J Immunol 2000; 165:1210-19.
40. Setoguchi R, Kinashi T, Sagara H, Hirosawa K, Takatsu K. Defective degranulation and calcium mobilization of bone-marrow derived mast cells from Xid and Btk-deficient mice. Immunol Lett 1998; 64:109-18.
41. Quek LS, Bolen J, Watson SP. A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen. Curr Biol 1998; 8:1137-40.
42. Tibbles H, Vassilev A, Uckun FM. A dual function anti-leukemic agent with anti-thrombotic activity. Leuk Lymph 2002; 43:1121-7.
43. Akiba H, Takeda K, Kojima Y etal. The role of ICOS in the CXCR5 follicular B helper T cell maintenance in vivo. J Immunol 2005; 175:2340-8.
44. Bossaller L, Burger J, Draeger R etal. ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells. J Immunol 2006; 177:4927-32.
45. Hardtke S, Ohl L, Forster R. Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymphnode follicles and is essential for efficient B cell help. Blood 2005; 106:1924-31.
46. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med 2000; 192:1553-62.
47. Breitfeld D, Ohl L, Kremmer E etal. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 2000; 192:1545-52.
48. Ansel KM, McHeyzer-Williams LJ, Ngo VN, McHeyzer-Williams MG, Cyster JG. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J Exp Med 1999; 190:1123-34.
49. Good RA. Clinical investigations in patients with agammaglobulinaemia. J Lab Clin Med 1954; 44:803.
50. Sideras P, Smith CIE. Molecular and cellular aspects of X-linked agammaglobulinaemia. Adv Immunol 1995; 59:135-223.